Lipum AB Logo

Lipum AB

LIPUM | FN

Overview

Corporate Details

ISIN(s):
SE0015660899 (+1 more)
LEI:
549300V7JL0004BHBD93
Country:
Sweden
Address:
Tvistevägen 48 C, 907 36 Umeå
Website:
N/A
Sector:
Health Care
Industry:
Biotechnology

Description

Lipum AB develops innovative treatments for chronic inflammatory diseases. Their lead drug candidate targets rheumatoid arthritis.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-14 Peter Hovstadius Other Sell 2,000 28,260.00 SEK
2025-04-14 Peter Hovstadius Other Sell 1,500 22,770.00 SEK
2025-04-14 Peter Hovstadius Other Sell 1,500 21,030.00 SEK

Peer Companies

Company Country Ticker View
Nattaro Labs AB Logo Nattaro Labs AB Sweden NATTA
Neovacs Logo Neovacs France ALNEV
Newron Pharmaceuticals S.p.A. Logo Newron Pharmaceuticals S.p.A. Italy NWRN
NextCell Pharma AB Logo NextCell Pharma AB Sweden NXTCL
NextFerm Technologies Ltd. Logo NextFerm Technologies Ltd. Israel NXFR
NFL Biosciences Logo NFL Biosciences France ALNFL
Nortem BioGroup Logo Nortem BioGroup Spain MLBIO
Novo Nordisk Logo Novo Nordisk Denmark NOVO
NRGene Technologies Ltd. Logo NRGene Technologies Ltd. Israel NRGN
NUFORMIX PLC Logo NUFORMIX PLC United Kingdom NFX